Aurobindo Pharma reports 4% rise in Q1 consolidated net profit

13 Aug 2015 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2015.

The company has reported 3.21% rise in its net profit at Rs 406.02 crore for the quarter ended June 30, 2015 as compared to Rs 393.40 crore for the same quarter in the previous year. The company’s total income has increased by 14.70% to Rs 2244.37 crore for the quarter under review from Rs 1956.69 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 4.09% rise in its net profit after taxes and minority interest at Rs 432.44 crore for the quarter ended June 30, 2015 as compared to Rs 415.43 crore for the same quarter in the previous year. Total income of the company has increased by 14.63% at Rs 3349.47 crore for quarter under review as compared to Rs 2921.88 crore for the quarter ended June 30, 2014.

During the previous year, on December 4, 2014, the company's USA subsidiary Aurobindo Pharma USA Inc. has acquired Natrol LLC, USA. The above Consolidated results for the quarter ended June 30, 2015 and for the quarter ended and year ended March 31, 2015 includes financial results of operations of Natrol LLC, USA from December 4, 2014. The corresponding figures of the quarter ended June 30, 2014 are not comparable.

Aurobindo Pharma Share Price

1141.65 11.50 (1.02%)
28-Jan-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.90
Dr. Reddys Lab 1240.05
Cipla 1315.00
Zydus Lifesciences 890.75
Lupin 2147.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×